UBS Group began coverage on shares of ARM (NASDAQ:ARM – Free Report) in a research note issued to investors on Monday, MarketBeat Ratings reports. The firm issued a buy rating and a $160.00 price target on the stock.
Other research analysts have also issued research reports about the company. Daiwa Capital Markets upgraded ARM from a “neutral” rating to an “outperform” rating and set a $130.00 price target for the company in a research report on Thursday, August 8th. Benchmark started coverage on shares of ARM in a research note on Monday, September 16th. They set a “hold” rating on the stock. The Goldman Sachs Group boosted their price target on shares of ARM from $144.00 to $159.00 and gave the stock a “buy” rating in a research report on Thursday, November 7th. Needham & Company LLC reissued a “hold” rating on shares of ARM in a report on Thursday, November 7th. Finally, Hsbc Global Res raised ARM to a “moderate sell” rating in a research note on Monday, July 29th. Two analysts have rated the stock with a sell rating, six have issued a hold rating, eighteen have issued a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, ARM presently has an average rating of “Moderate Buy” and an average price target of $150.32.
Read Our Latest Stock Report on ARM
ARM Trading Down 2.5 %
ARM (NASDAQ:ARM – Get Free Report) last announced its quarterly earnings results on Wednesday, November 6th. The company reported $0.30 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.26 by $0.04. The company had revenue of $844.00 million during the quarter, compared to the consensus estimate of $810.03 million. ARM had a net margin of 18.13% and a return on equity of 13.69%. The company’s revenue for the quarter was up 4.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.36 earnings per share. As a group, equities analysts forecast that ARM will post 0.79 earnings per share for the current fiscal year.
Institutional Investors Weigh In On ARM
Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Franklin Resources Inc. raised its position in shares of ARM by 21.7% in the third quarter. Franklin Resources Inc. now owns 1,281,484 shares of the company’s stock valued at $183,265,000 after purchasing an additional 228,467 shares during the period. International Assets Investment Management LLC grew its stake in ARM by 14,351.1% in the 3rd quarter. International Assets Investment Management LLC now owns 812,297 shares of the company’s stock valued at $1,161,670,000 after buying an additional 806,676 shares during the last quarter. Sei Investments Co. raised its holdings in ARM by 551.6% in the 2nd quarter. Sei Investments Co. now owns 579,330 shares of the company’s stock worth $94,790,000 after acquiring an additional 490,415 shares during the period. Mirae Asset Global Investments Co. Ltd. lifted its position in ARM by 186.8% during the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 359,105 shares of the company’s stock worth $52,279,000 after acquiring an additional 233,909 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD boosted its holdings in ARM by 5.3% during the first quarter. Price T Rowe Associates Inc. MD now owns 290,947 shares of the company’s stock valued at $36,366,000 after acquiring an additional 14,584 shares during the period. 7.53% of the stock is currently owned by institutional investors and hedge funds.
About ARM
Arm Holdings plc architects, develops, and licenses central processing unit products and related technologies for semiconductor companies and original equipment manufacturers rely on to develop products. It offers microprocessors, systems intellectual property (IPs), graphics processing units, physical IP and associated systems IPs, software, tools, and other related services.
Recommended Stories
- Five stocks we like better than ARM
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Best Stocks Under $5.00
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- How to Use High Beta Stocks to Maximize Your Investing Profits
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for ARM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ARM and related companies with MarketBeat.com's FREE daily email newsletter.